Tribendimidine: great expectations

The Lancet Infectious Diseases

Volumn 16, Issue 10, 2016, Pages 1089-1091

  Bergquist, Robert ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Brastad   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; PRAZIQUANTEL; TRIBENDIMIDINE; UNCLASSIFIED DRUG;

DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; NONHUMAN; NOTE; OPISTHORCHIASIS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 84990061951     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30231-6     Document Type: Note

References (13)

1. 1 Tambo, E, Khater, EI, Chen, JH, Bergquist, R, Zhou, XN, Nobel prize for the artemisinin and ivermectin discoveries: a great boost towards elimination of the global infectious diseases of poverty. Infect Dis Poverty, 4, 2015, 58.
2. 2 Xiao, SH, Utzinger, J, Tanner, M, Keiser, J, Xue, J, Advances with the Chinese anthelminthic drug tribendimidine in clinical trials and laboratory investigations. Acta Trop 126 (2013), 115–126.
3. 3 Xiao, SH, Hui-Ming, W, Tanner, M, Utzinger, J, Chong, W, Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China. Acta Trop 94 (2005), 1–14.
4. 4 Keiser, J, Xiao, SH, Chollet, J, Tanner, M, Utzinger, J, Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini. Antimicrob Agents Chemother 51 (2007), 1096–1098.
5. 5 Keiser, J, Utzinger, J, Xiao, SH, Odermatt, P, Tesana, S, Opisthorchis viverrini: efficacy and tegumental alterations following administration of tribendimidine in vivo and in vitro. Parasitol Res 102 (2008), 771–776.
6. 6 Qian, MB, Yap, P, Yang, YC, et al. Efficacy and safety of tribendimidine against Clonorchis sinensis. Clin Infect Dis 56 (2013), e76–e82.
7. 7 Sripa, B, Bethony, JM, Sithithaworn, P, et al. Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop 120:suppl 1 (2011), S158–S168.
8. 8 Lun, ZR, Gasser, RB, Lai, DH, et al. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis 5 (2005), 31–41.
9. 9 Sayasone, S, Odermatt, P, Vonghachack, Y, et al. Efficacy and safety of tribendimidine against Opisthorchis viverrini: two randomised, parallel-group, single-blind, dose-ranging, phase 2 trials. Lancet Infect Dis, 2016 published online July 26. http://dx.doi.org/10.1016/S1473-3099(16)30198-0.
10. 10 WJ, You, JQ, Yang, YQ, et al. Studies on the efficacy of artemether in experimental schistosomiasis. Yao Xue Xue Bao 17 (1982), 187–193.
11. 11 Keiser, J, Utzinger, J, Antimalarials in the treatment of schistosomiasis. Curr Pharm Des 18 (2012), 3531–3538.
12. 12 Liu, YX, Wu, W, Liang, YJ, et al. New uses for old drugs: the tale of artemisinin derivatives in the elimination of Schistosomiasis japonica in China. Molecules 19 (2014), 15058–15074.
13. 13 Panic, G, Duthaler, U, Speich, B, Keiser, J, Repurposing drugs for the treatment and control of helminth infections. Int J Parasitol Drugs Drug Resist 4 (2014), 185–200.